For example, the conformation-specific features of AD tau fibrils guided the development and optimization of PET ligands such as [18F] PI-2620, enhancing early diagnosis and monitoring of tauopathies (Fitzpatrick et al., 2017; Kroth et al., 2019). This evidence concerns the gene MAPT and Alzheimer disease.